TrialPath
Recruiting

Pocket-X Gel Non-surgical Periodontal Therapy

NCT07372677 · Universita di Verona
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Clinical and Microbiological Effects of a Thermal-Gel Device in Periodontal Treatment: Diabetic vs Non-Diabetic Patients
About this study
Evaluate from a clinical and microbiological point of view the effect of an adjunctive therapy based on a thermal-gelling device Pocket-X® Gel (Hyaluronic acid, Poloxamer, 2-Phenoxyethanol, Octedine HCL, Water), in the non-surgical treatment of periodontal defects, in a population of patients with T2DM compared to non-diabetic patients. Determine whether periodontal defect healing is clinically and microbiologically different between T2DM patients and non-diabetic patients; whether periodontal treatment and maintenance can lead to improvement of conditions and stability over time also for diabetic conditions.
Eligibility criteria
Inclusion Criteria: Patients normally eligible for the visit and for the non-surgical type of treatment for periodontal defects: * patients with an age between 18 and 80; * patients with: (i) Asa status I (no functional impairment due to pathologies), (ii) patients with type 2 diabetes (T2DM) with: glycated hemoglobin level HbA1c between 6.5 and 8.0%, on dietary therapy and/or with hypoglycemic drugs in regular follow-up at the diabetes service; * patients with chronic periodontitis stage 3 or 4, according to the new classification of periodontal diseases \[Tonetti et al.\]), verified clinically and radiographically: patients will be selected with interdental clinical attachment level (CAL) at the site of greatest loss ≥3 mm to ≥2 non-adjacent teeth, probing depth (PPD) ≥5 mm, bleeding on probing (BoP) and horizontal and/or vertical radiographic bone loss. Exclusion Criteria: * Patients not eligible for the non-surgical type of treatment for periodontal defects: * patients with a positive history of diseases with functional impairment (ASA status 2,3,4) or severe handicaps that could limit the ability to attend appointments; * patients with uncontrolled/poorly controlled DM at the time of study selection (e.g. type 1 diabetes mellitus and secondary forms of diabetes); patients with uncontrolled and serious diabetic complications (cardiovascular, renal, hepatic and nervous); * poor compliance with treatment, with poor oral hygiene and motivation; * not signing informed consent by patients.
Study design
Enrollment target: 70 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2026-02-02
Estimated completion: 2030-01
Last updated: 2026-05-29
Interventions
Device: Gel therapy after non surgical therapy
Primary outcomes
  • • Clinical evaluation, in the test site and in the control site (for each of the two groups) of the periodontal index of: PPD in mm. (At baseline and after 2 weeks, 1 month, and 3 months)
Sponsor
Universita di Verona · other
Contacts & investigators
ContactAlessia Pardo · contact · Alessia.pardo@univr.it · +39 3494628471
All locations (1)
Alessia Pardo 3494628471 Alessia.pardo@univr.itRecruiting
Verona, Italy, Italy
Pocket-X Gel Non-surgical Periodontal Therapy · TrialPath